Reference number : 172-2025-2026-Q2-1032265, amendment number : , agreement type : C, recipient legal name : NORTHERN RNA INC., recipient country : CA, recipient province : AB, recipient city : Calgary|Calgary, recipient postal code : T2A 7H8, program name english : Industrial Research Assistance Program – Contributions to Firms, program name french : Programme d’aide à la recherche industrielle – Contributions aux entreprises, program purpose english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, program purpose french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, agreement title english : UK Biomanufacturing - 10140683 - H5Nx Vaccine - Pan-H5Nx subtype Influenza Protection: mRNA Vaccine Using optimized Lipid Nanoparticles, agreement title french : UK Biomanufacturing - 10140683 - Vaccin H5Nx - Protection contre le sous-type de grippe Pan-H5Nx : vaccin ARNm utilisant des nanoparticules lipidiques optimisées, agreement number : 1032265, agreement value : 498000.0, agreement start date : 2025-05-01, agreement end date : 2027-03-30, description english : “As part of the international consortium project “H5Nx Vaccine: Pan-H5Nx subtype Influenza Protection: mRNA Vaccine Using optimized Lipid Nanoparticles”, this project proposes to develop a groundbreaking biomanufacturing platform for a novel pan-H5Nx mRNA vaccine., description french : «Dans le cadre du projet de consortium international» H5Nx Vaccine : Pan-H5Nx subtype Influenza Protection : mRNA Vaccine Using optimized Lipid Nanoparticles”, ce projet propose de développer une plateforme de bioproduction révolutionnaire pour un nouveau vaccin ARNm pan-H5Nx., expected results english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, expected results french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, additional information english : nan, additional information french : nan, owner organization : nrc-cnrc, owner organization title : National Research Council Canada | Conseil national de recherches Canada